Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis (original) (raw)
Association between LDL, Apolipoprotein-B Apolipoprotein A-I and Lipoprotein(a) and Severity of Coronary Artery Disease Based on Coronary Angiography
Pradeep Perera
Journal of Biosciences and Medicines, 2015
View PDFchevron_right
The ratio of apoB/apoAI, apoB and lipoprotein(a) are the best predictors of stable coronary artery disease
Mehdi Rasouli
Clinical Chemistry and Laboratory Medicine (CCLM), 2006
View PDFchevron_right
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age
Colomba Falcone
Journal of The American College of Cardiology, 1999
View PDFchevron_right
Serum lipids, lipoprotein(a) level, and apolipoprotein(a) isoforms as prognostic markers in patients with coronary heart disease
Ulf Lundstam
Journal of Internal Medicine, 2002
View PDFchevron_right
Correlation Lipoprotein A Level with Complexity of Coronary Lesion in Coronary Heart Disease Patient at Rsup Dr. Sardjito Yogyakarta
Nahar Taufiq
Bangladesh Journal of Medical Science, 2016
View PDFchevron_right
Are Apolipoproteins A and B Better Than Lipoproteins for Assessing Risk of Obstructive Coronary Heart Disease?
Waldomiro Manfroi
Arquivos brasileiros de …, 1999
View PDFchevron_right
High Level of Lipoprotein (a) is a Strong Predictor for Progression of Coronary Artery Disease
Hiroyuki Daida
Journal of Atherosclerosis and Thrombosis, 1998
View PDFchevron_right
Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with established coronary artery disease and their relation to disease and prognosis after coronary by-pass surgery
Wendy Taddei-Peters
Atherosclerosis, 1998
View PDFchevron_right
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects
Colomba Falcone
Diabetic Medicine, 2001
View PDFchevron_right
Apolipoprotein(a) Size and Lipoprotein(a) Concentration and Future Risk of Angina Pectoris with Evidence of Severe Coronary Atherosclerosis in Men: The Physicians' Health Study
Steffen Gloekler
Clinical Chemistry, 2004
View PDFchevron_right
Comparison of apolipoprotein levels with conventional Lipid profile parameters in patients with coronary heart disease
pratik raghavani, IP Innovative Publication Pvt. Ltd.
IP innovative publication pvt. ltd, 2019
View PDFchevron_right
Original ArticleOrigi al Article Increased Serum Levels of Lipoprotein(a) Correlated with the Severity of Coronary Artery Disease in Patients Submitted to Angiography
Maria das Graças Carvalho
2016
View PDFchevron_right
Evaluation of apolipoproteins A-I and B as markers of angiographically assessed coronary artery disease
Mariastella Graziani
La Ricerca in Clinica e in Laboratorio, 1988
View PDFchevron_right
Increased Plasma Lipid-Poor Apolipoprotein A-I in Patients with Coronary Artery Disease
Mitsuru Seishima
Clinical Chemistry, 2004
View PDFchevron_right
Clinical significance of lipoprotein size and risk for coronary atherosclerosis
Bela Asztalos
Clinical chemistry, 1995
View PDFchevron_right
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment
Curt Furberg, Allan Sniderman
The Lancet, 2003
View PDFchevron_right
Value of HDL Cholesterol, Apolipoprotein A-I, Lipoprotein A-I, and Lipoprotein A-I/A-II in Prediction of Coronary Heart Disease: The PRIME Study
Jean-marie Bard
Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
View PDFchevron_right
premature coronary artery disease Association of apolipoprotein(a) phenotypes in children with family history of
Bernard Gutin
2010
View PDFchevron_right
Association of Apolipoprotein B/Apolipoprotein A1 Ratio and Coronary Artery Stenosis and Plaques Detected by Multi-Detector Computed Tomography in Healthy Population
Hamidreza Roohafza
Journal of Korean Medical Science, 2013
View PDFchevron_right
Apolipoprotein(a) Size and Lipoprotein(a) Concentrations in Patients with Good and Poor Coronary Collateral Flow – an Interrelation Discovered by Proteomic Screening of Pooled Plasma Samples
Steffen Gloekler
Journal of Proteomics Bioinformatics, 2008
View PDFchevron_right
Lipoprotein(a) levels, apo(a) isoform size, and coronary heart disease risk in the Framingham Offspring Study
John Albers
The Journal of Lipid Research, 2011
View PDFchevron_right
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
Elena Utkina
Atherosclerosis. Supplements, 2013
View PDFchevron_right
Lipoprotein (a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions
Ana Osa
Haematologica, 2006
View PDFchevron_right
Combined Effects of Small Apolipoprotein (a) Isoforms and Small, Dense LDL on Coronary Artery Disease Risk
Aleksandra Zeljkovic
Archives of Medical Research, 2009
View PDFchevron_right
Correlation between lipoprotein(a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score
Reza Hamidian
Clinical Biochemistry, 2008
View PDFchevron_right
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study
Jean-marie Bard
Atherosclerosis, 2002
View PDFchevron_right
Lipoprotein(a) and its position among other risk factors of atherosclerosis
Richard Ceska
Physiological research / Academia Scientiarum Bohemoslovaca, 2008
View PDFchevron_right